Hypertriglyceridemia as a Result of Human apo CII Gene Expression in Transgenic Mice
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Primary and secondary hypertriglyceridemia is common in the general population, but the biochemical basis for this disease is largely unknown. With the use of transgenic technology, two lines of mice were created that express the human apolipoprotein CIII gene. One of these mouse lines with 100 copies of the gene was found to express large amounts of the protein and to be severely hypertriglyceridemic. The other mouse line with one to two copies of the gene expressed low amounts of the protein, but nevertheless manifested mild hypertriglyceridemia. Thus, overexpression of apolipoprotein CIII can be a primary cause of hypertriglyceridemia in vivo and may provide one possible etiology for this common disorder in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“High ApoC-III levels were shown to increase total triglyceride levels by an accumulation of VLDL and chylomicrons [166–169]”
From Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention (2023) · cites this paper as [167]
In the citing paper
“These data are consistent with previous studies showing that transgenic mice with overexpression of human apolipoprotein C3 had hypertriglyceridemia due to decreased lipoprotein lipase activity,16”
From Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease (2010) · cites this paper as [16]
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control
Lenardo, M. J., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90833-7 · Cited by 1,585
Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein
Virgil Brown, W., & Baginsky, M. L. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(72)80149-9 · Cited by 491
Ginsberg, H. N., Le, N. A., Goldberg, I. J., Gibson, J. C., Rubinstein, A., Wang-Iverson, P., Norum, R., & Brown, W. V. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112713 · Cited by 424
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
Wang, C. S., McConathy, W. J., Kloer, H. U., & Alaupovic, P. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111711 · Cited by 414
Karathanasis, S. K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6374 · Cited by 358
PLASMA TRIGLYCERIDE AS A RISK FACTOR FOR CORONARY HEART DISEASE
AUSTIN, M. A. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115130 · Cited by 352
Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery Disease
Norum, R. A., Lakier, J. B., Goldstein, S., Angel, A., Goldberg, R. B., Block, W. D., Noffze, D. K., Dolphin, P. J., Edelglass, J., Bogorad, D. D., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206243062503 · Cited by 304
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112926 · Cited by 261
Self-citationWalsh, A., Ito, Y., & Breslow, J. L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83374-9 · Cited by 241
Self-citation
Research works printed but not linked: 2
- COLE, T.G., BIOCOMMUNIQUE 4: 4 (1988).
- PROTTER, A. A., DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY 3: 449 (1984).
Cited by
Items 201–300 of 543
Pollex, R. L., Ban, M. R., Young, T. K., Bjerregaard, P., Anand, S. S., Yusuf, S., Zinman, B., Harris, S. B., Hanley, A. J., Connelly, P. W., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-80 · Cited by 45
Zhang, Y., He, W., He, C., Wan, J., Lin, X., Zheng, X., Li, L., Li, X., Yang, X., Yu, B., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1969-3 · Cited by 49
trans-Caryophyllene is a natural agonistic ligand for peroxisome proliferator-activated receptor-α
Wu, C., Jia, Y., Lee, J. H., Jun, H., Lee, H.-S., Hwang, K.-Y., & Lee, S. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.04.112 · Cited by 54
Transgenic Animals in Cardiovascular Disease Research
Bäder, M., Bohnemeier, H., Zollmann, F. S., Lockley, O. E., & Ganten, D. (2000) · Experimental Physiology · doi:10.1111/j.1469-445x.2000.02096.x · Cited by 50
Mitogen-activated Protein Kinase Regulates Transcription of the ApoCIII Gene
Reddy, S., Yang, W., Taylor, D. G., Shen, X.-Q., Oxender, D., Kust, G., & Leff, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.33050 · Cited by 49
Groenendijk, M., Cantor, R. M., Blom, N. H. H. C., Rotter, J. I., de Bruin, T. W. A., & Dallinga-Thie, G. M. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33507-0 · Cited by 47
Sun, H.-Y., Lin, C., Lee, J., Wang, S.-W., Cheng, P., Wu, I., Chang, T., Lai, M., Shieh, D., & Young, K.-C. (2012) · Gut · doi:10.1136/gutjnl-2011-301798 · Cited by 47
Metabolic and genetic control of HDL cholesterol levels
Tall, A. R. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb01255.x · Cited by 46
Wijsman, E. M., Brunzell, J. D., Jarvik, G. P., Austin, M. A., Motulsky, A. G., & Deeb, S. S. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.2.215 · Cited by 46
Connelly, P. W., Maguire, G. F., Vezina, C., Hegele, R. A., & Kuksis, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32029-x · Cited by 43
Dai, W., Zhang, Z., Yao, C., & Zhao, S. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1166-5 · Cited by 47
Henderson, H., Leisegang, F., Hassan, F., Hayden, M. R., & Marais, D. A. (1998) · Clinica Chimica Acta · doi:10.1016/s0009-8981(97)00144-7 · Cited by 44
The Regulation of Triacylglycerol Metabolism and Lipoprotein Lipase Activity
Wen, Y., Chen, Y., & Konrad, R. J. (2022) · Advanced Biology · doi:10.1002/adbi.202200093 · Cited by 53
Liu, H., Labeur, C., Xu, C.-F., Ferrell, R., Lins, L., Brasseur, R., Rosseneu, M., Weiss, K. M., Humphries, S. E., & Talmud, P. J. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31969-6 · Cited by 41
Reaven, G. M., Mondon, C. E., Chen, Y. D., & Breslow, J. L. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39176-8 · Cited by 43
Self-citationAlterations in Lipoprotein Composition in Peritoneal Dialysis Patients
Moberly, J. B., Attman, P., Samuelsson, O. G., Johansson, A., Knight‐Gibson, C., & Alaupovic, P. (2002) · Peritoneal Dialysis International · doi:10.1177/089686080202200209 · Cited by 43
Barthelemy-Clavey, V., Copin, C., Mariotte, M. C., Baugé, E., Chinetti, G., Fruchart, J., Fruchart, J. C., Dallongeville, J., & Staels, B. (1999) · Cellular Physiology and Biochemistry · doi:10.1159/000016311 · Cited by 45
Kardassis, D., Tzameli, I., Hadzopoulou‐Cladaras, M., Talianidis, I., & Zannis, V. I. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.1.222 · Cited by 56
Hoffer, Sijbrands, E. J. G., Man, D., Havekes, Smelt, & Frants (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00361.x · Cited by 46
Rosenthal, E. A., Ranchalis, J., Crosslin, D. R., Burt, A., Brunzell, J. D., Motulsky, A. G., Nickerson, D. A., Wijsman, E. M., & Jarvik, G. P. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.10.019 · Cited by 44
High-density lipoprotein and transport of cholesterol and triglyceride in blood
Brown, W. V. (2007) · Journal of clinical lipidology · doi:10.1016/j.jacl.2007.02.001 · Cited by 45
Hong, S. H., Park, W. H., Lee, C. C., Song, J. H., & Kim, J. Q. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.1.13 · Cited by 43
Kardassis, D., Pardali, K., & Zannis, V. I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007896200 · Cited by 42
Ribalta, J., La Ville, A. E., Vallvé, J. C., Humphries, S., Turner, P. R., & Masana, L. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37189-3 · Cited by 42
Paiva, A. A., Raposo, H. F., Wanschel, A. C. B. A., Nardelli, T. R., & Oliveira, H. C. F. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1838679 · Cited by 44
Han, Z., Heath, S. C., Shmulewitz, D., Li, W., Auerbach, S. B., Blundell, M. L., Lehner, T., Ott, J., Stoffel, M., Friedman, J. M., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10445 · Cited by 44
Self-citationBrown, S., Ordovás, J. M., & Campos, H. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00293-4 · Cited by 48
Alberici, L. C., Oliveira, H. C. F., Patrício, P. R., Kowaltowski, A. J., & Vercesi, A. E. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.021 · Cited by 43
Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians
Chhabra, S., Narang, R., Krishnan, L., Vasisht, S., Agarwal, D., Lm, S., Manchanda, S., & Das, N. (2002) · BMC Genetics · doi:10.1186/1471-2156-3-9 · Cited by 43
Ko, Y., Ko, Y., Wu, S.-M., Teng, M., Chen, F.-R., Hsu, T., Chiang, C.-W., & Lee, Y. (1997) · Human Genetics · doi:10.1007/s004390050511 · Cited by 41
Apo CIII gene transcription is regulated by a cytokine inducible NF-χB element
Gruber, P. J., Torres-Rosado, A., Wolak, M. L., & Left, T. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.12.2417 · Cited by 40
Ruixing, Y., Li, Y., Li, M., Kela, L., Xingjiang, L., Lin, Z., Wanying, L., Wu, J., Dezhai, Y., & Weixiong, L. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-86 · Cited by 39
Apolipoprotein CIII Deficiency Protects Against Atherosclerosis in Knockout Rabbits
Yan, H., Niimi, M., Matsuhisa, F., Zhou, H., Kitajima, S., Chen, Y., Wang, C., Yang, X., Yao, J. Q., Yang, D., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314368 · Cited by 43
Andersson, Y., Majd, Z., Lefebvre, A.-M., Martin, G., Sechkin, A. V., Kosykh, V., Fruchart, J.-C., Najib, J., & Staels, B. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.1.115 · Cited by 39
Wang, X., Gong, Y., Deng, T., Zhang, L., Liao, X., Han, C., Yang, C., Huang, J., Wang, Q., Song, X., et al. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29131 · Cited by 43
Vergnes, L., Taniguchi, T., Omori, K., Zakin, M. M., & Ochoa, A. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00071-4 · Cited by 43
Lipoprotein Transport Gene Abnormalities Underlying Coronary Heart Disease Susceptibility
Breslow, J. L. (1991) · Annual Review of Medicine · doi:10.1146/annurev.me.42.020191.002041 · Cited by 43
Self-citationMyeloperoxidase: Localization, Structure, and Function
Tobler, A., & Koeffler, H. P. (1991) · Blood cell biochemistry · doi:10.1007/978-1-4615-3796-0_10 · Cited by 38
Apolipoprotein C-III and cardiovascular diseases: when genetics meet molecular pathologies
Dib, I., Khalil, A., Chouaib, R., El-Makhour, Y., & Noureddine, H. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06071-5 · Cited by 40
Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content
Peter, A., Kantartzis, K., Machicao, F. E., Machann, J., Wagner, S., Templin, S., Königsrainer, I., Königsrainer, A., Schick, F., Fritsche, A., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.154 · Cited by 42
Mitochondrial energy metabolism and redox responses to hypertriglyceridemia
Alberici, L. C., Vercesi, A. E., & Oliveira, H. C. F. (2011) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-011-9326-y · Cited by 39
Marçais, C., Bernard, S., Merlin, M., Ulhmann, M., Mestre, B., Rochet-Mingret, L., Revol, A., Berthezène, F., & Moulin, P. (2000) · Diabetologia · doi:10.1007/s001250051537 · Cited by 41
Tilly, P., Sass, C., Vincent-Viry, M., Aguillon, D., Siest, G., & Visvikis, S. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200006-jlr200 · Cited by 35
Khoo, C., Campos, H., Judge, H., & Sacks, F. M. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33358-7 · Cited by 37
Balog, C. I. A., Mayboroda, O. A., Wuhrer, M., Hokke, C. H., Deelder, A. M., & Hensbergen, P. J. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900537-mcp200 · Cited by 40
Li, M.-R., Zhang, S., Chao, K., Liao, X., Yao, J., Chen, M., & Zhong, B. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i38.14010 · Cited by 38
Ding, Y., Wang, Y., Zhu, H., Fan, J., Yu, L., Liu, C., & Liu, E. (2010) · Transgenic Research · doi:10.1007/s11248-010-9467-5 · Cited by 40
Yokoyama, I., Ohtake, T., Momomura, S., Yonekura, K., Kobayakawa, N., Aoyagi, T., Sugiura, S., Sasaki, Y., & Omata, M. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.2.294 · Cited by 36
Humphries, S. E., Talmud, P. J., Cox, C., Sutherland, W. H. F., & Mann, J. I. (1996) · QJM · doi:10.1093/qjmed/89.9.671 · Cited by 36
Postprandial lipemia and coronary risk
Patsch, W., Esterbauer, H., Föger, B., & Patsch, J. R. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0025-0 · Cited by 40
Januzzi, J. L., Azrolan, N., O'Connell, A. M., Aalto‐Setälä, K., & Breslow, J. L. (1992) · Genomics · doi:10.1016/s0888-7543(05)80133-8 · Cited by 36
Self-citationAPOC3 siRNA and ASO therapy for dyslipidemia
Chebli, J., Larouche, M., & Gaudet, D. (2024) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000857 · Cited by 35
The C Terminus of Apolipoprotein A-V Modulates Lipid-binding Activity
Beckstead, J. A., Mauldin, K., Gupta, V., Wan, C.-P. L., Cook, V. R., Weinberg, R. B., Weers, P. M. M., & Ryan, R. O. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611797200 · Cited by 36
Lüttmann, S., von Eckardstein, A., Wei, W., Funke, H., Köhler, E., Mahley, R. W., & Assmann, G. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40084-7 · Cited by 35
Su, J. W., Nzekwu, M. M. U., Cabezas, M. C., Redgrave, T. G., & Proctor, S. D. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02179.x · Cited by 34
Gene Polymorphism and Coronary Risk Factors in Indian Population
Ashavaid, T. F., Shalia, K. K., Kondkar, A. A., Todur, S. P., Nair, K. G., & Nair, S. (2002) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2002.171 · Cited by 35
Kan, H.-Y., Georgopoulos, S., & Zannis, V. I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005641200 · Cited by 42
Sijbrands, E. J. G., Hoffer, M. J. V., Meinders, A. E., Havekes, L. M., Frants, R. R., Smelt, A. H. M., & De Knijff, P. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.11.2722 · Cited by 33
Fraser, J. D., Keller, D., Martinez, V., Santiso‐Mere, D., Straney, R. A., & Briggs, M. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13892 · Cited by 35
Association of Triglyceride-Related Genetic Variants With Mitral Annular Calcification
Afshar, M. S., Luk, K., Do, R., Dufresne, L., Owens, D. S., Harris, T. B., Peloso, G. M., Kerr, K. F., Wong, Q., Smith, A. V., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.051 · Cited by 35
Vergnes, L., Baroukh, N., Ostos, M. A., Castro, G. R., Duverger, N., Nanjee, M. N., Najïb, J., Fruchart, J., Miller, N. E., Zakin, M. M., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.10.2267 · Cited by 33
Kardassis, D., Laccotripe, M., Talianidis, I., & Zannis, V. I. (1996) · Hypertension · doi:10.1161/01.hyp.27.4.980 · Cited by 37
Swanson, M. E., Hughes, T. E., Denny, I. S., France, D. S., Paterniti, J. R., Tapparelli, C., Gfeller, P., & Bürki, K. (1992) · Transgenic Research · doi:10.1007/bf02528779 · Cited by 33
Loss-of-Function CREB3L3 Variants in Patients With Severe Hypertriglyceridemia
Dron, J. S., Dilliott, A. A., Lawson, A., McIntyre, A. D., Davis, B. D., Wang, J., Cao, H., Movsesyan, I., Malloy, M. J., Pullinger, C. R., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314168 · Cited by 33
Apolipoprotein C-III, Hypertriglyceridemia and Triglyceride-Rich Lipoproteins in Uremia
Moberly, J. B., Attman, P., Samuelsson, O. G., Johansson, A., Knight‐Gibson, C., & Alaupovic, P. (1999) · Mineral and Electrolyte Metabolism · doi:10.1159/000057457 · Cited by 32
Genetic risk for coronary artery disease in individuals with or without type 2 diabetes
Yamada, Y., Ichihara, S., Izawa, H., Tanaka, M., & Yokota, M. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.01.014 · Cited by 32
Hegele, R. A. (2016) · Journal of Lipid Research · doi:10.1194/jlr.c070946 · Cited by 31
“Transgenic overexpression of human APOC3 in mice is associated with severe hypertriglyceridemia (32), while targeted deletion of murine Apoc3 is associated with low TG and protection from postprandial hypertriglyceridemia (33).”
BackgroundOverexpression of apolipoprotein C-III decreases secretion of dietary triglyceride into lymph
Wang, F., Kohan, A. B., Dong, H. H., Yang, Q., Xu, M., Huesman, S., Lou, D., Hui, D. Y., & Tso, P. (2014) · Physiological Reports · doi:10.1002/phy2.247 · Cited by 29
Cohn, J. S., Rodriguez, C., Jacques, H., Tremblay, M., & Davignon, J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.d300041-jlr200 · Cited by 29
Rat Inbred PD/Cub Strain as a Model of Dyslipidemia and Insulin Resistance
Šedová, L., Kazdová, L., Šeda, O., Krenová, D., & Křen, V. (2000) · Folia Biologica · doi:10.14712/fb2000046030099 · Cited by 34
Linkage analysis of candidate genes and the small, dense low-density lipoprotein phenotype
Austin, M. A., Stephens, K. G., Walden, C. E., & Wijsman, E. M. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00193-2 · Cited by 31
van der Hoogt, C. C., Berbée, J. F. P., Santo, S. M. S. E., Gerritsen, G., Krom, Y. D., van der Zee, A., Havekes, L. M., van Dijk, K. W., & Rensen, P. C. N. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.01.002 · Cited by 32
Aromatic residues in the C terminus of apolipoprotein C-III mediate lipid binding and LPL inhibition
Meyers, N. L., Larsson, M., Vorrsjö, E., Olivecrona, G., & SMALL, D. M. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m071126 · Cited by 30
Catapano, A. L. (1992) · Pharmacological Research · doi:10.1016/1043-6618(92)90232-z · Cited by 32
A peptide from hog plasma that inhibits human cholesteryl ester transfer protein
Cho, K., Lee, J.-Y., Choi, M., Cho, J. M., Lim, J.-S., & Park, Y. B. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00197-5 · Cited by 31
Li, D., Rodia, C. N., Johnson, Z. K., Bae, M., Muter, A., Heussinger, A. E., Tambini, N. S., Longo, A. M., Dong, H., Lee, J., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m092460 · Cited by 31
The lipolysis stimulated receptor: a gene at last
Bihain, B. E., & Yen, F. T. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199806000-00006 · Cited by 31
Vedie, B., Jeunemaı̂tre, X., Mégnien, J. L., Myara, I., Trebeden‐Negre, H., Simon, A. C., & MOATTI, N. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.11.1780 · Cited by 29
Patsch, W., & Gotto, A. M. (1995) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61018-2 · Cited by 31
Lacorte, J., Ktistaki, E., Beigneux, A. P., Zannis, V. I., Chambaz, J., & Talianidis, I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23578 · Cited by 35
Nishizawa, Y., Shoji, T., Nishitani, H., Yamakawa, M., Konishi, T., Kawasaki, K., & Morii, H. (1993) · Kidney International · doi:10.1038/ki.1993.388 · Cited by 29
Ogami, K., Kardassis, D., Cladaras, C., & Zannis, V. I. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92868-1 · Cited by 29
Paclitaxel and platinum-based chemotherapy results in transient dyslipidemia in cancer patients
Wang, G., Su, C., & Yin, T. (2016) · Molecular and Clinical Oncology · doi:10.3892/mco.2016.1107 · Cited by 30
Patsch, W., Sharrett, A. R., Ing-Jun, C. H. E. N., Lin-Lee, Y.-C., Brown, S. A., Gotto, A. M., & Boerwinkle, E. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.6.874 · Cited by 32
The mouse model for atherosclerosis
Lusis, A. J. (1993) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(93)90014-w · Cited by 29
Naganawa, S., Ginsberg, H. N., Glickman, R. M., & Ginsburg, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119363 · Cited by 29
Lindquist, C., Bjørndal, B., Rossmann, C. R., Tusubira, D., Svardal, A. M., Røsland, G. V., Tronstad, K. J., Hallström, S., & Berge, R. K. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m074849 · Cited by 27
Lightbourne, M., Startzell, M. S., Bruce, K. D., Brite, B., Muniyappa, R., Skarulis, M. C., Shamburek, R. D., Gharib, A. M., Ouwerkerk, R., Walter, M. F., et al. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.06.011 · Cited by 27
Oxidative Stress and Inflammation in Renal Patients and Healthy Subjects
Lee, D. M., Jackson, K. W., Knowlton, N. S., Wages, J., Alaupovic, P., Samuelsson, O. G., Saeed, A., Centola, M. B., & Attman, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022360 · Cited by 29
The Ins and Outs of Adipose Tissue
Olivecrona, T., & Olivecrona, G. (2009) · Springer eBooks · doi:10.1007/978-3-642-00300-4_13 · Cited by 33
Puglisi, M. J., Mutungi, G., Brun, P., McGrane, M. M., Labonte, C. C., Volek, J. S., & Fernández, M. L. (2008) · Metabolism · doi:10.1016/j.metabol.2008.08.014 · Cited by 28
Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin
Dallinga‐Thie, G. M., Groenendijk, M., Blom, R. N. H. H. C., de Bruin, T. W., & de Kant, E. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30278-9 · Cited by 28
Lipids and apolipoproteins in growth hormone-deficient children during treatment
Schaefer, G. B., Greger, N. G., Fesmire, J., Blackett, P. R., Wilson, D. P., & Frindik, J. P. (1994) · Metabolism · doi:10.1016/0026-0495(94)90001-9 · Cited by 32
γ-secretase inhibition lowers plasma triglyceride-rich lipoproteins by stabilizing the LDL receptor
Kim, K., Goldberg, I. J., Graham, M. J., Sundaram, M., Bertaggia, E., Lee, S. X., Qiang, L., Haeusler, R. A., Metzger, D., Chambon, P., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.010 · Cited by 26
Role of MAPK in apolipoprotein CIII-induced apoptosis in INS-1E cells
Sol, E.-R. M., Sundsten, T., & Bergsten, P. (2009) · Lipids in Health and Disease · doi:10.1186/1476-511x-8-3 · Cited by 26
The Role of Dyslipidemia on Ocular Surface, Lacrimal and Meibomian Gland Structure and Function
Módulo, C. M., Filho, E. B. M., Malki, L. T., Dias, A. C., de Souza, J. C., Oliveira, H. C. F., Jorge, I., Gomes, I. B. S., Meyrelles, S. S., & Rocha, E. M. (2012) · Current Eye Research · doi:10.3109/02713683.2011.631720 · Cited by 27
Raposo, H. F., Paiva, A. A., Kato, L. S., & Oliveira, H. C. F. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0058-6 · Cited by 27
Butler, A. A., Price, C. A., Graham, J. L., Stanhope, K. L., King, S. M., Hung, Y.-H., Sethupathy, P., Wong, S. C., Hamilton, J., Krauss, R. M., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m089508 · Cited by 25
Lipolytic enzymes and free fatty acids at the endothelial interface
Goldberg, I. J., Cabodevilla, A. G., Samovski, D., Cifarelli, V., Basu, D., & Abumrad, N. A. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.05.018 · Cited by 25
Wölter, M., Röwer, C., Koy, C., Reimer, T., Rath, W. H., Pecks, U., & Glocker, M. O. (2012) · Electrophoresis · doi:10.1002/elps.201200001 · Cited by 26
Metadata
- Authors
- Ito, Y., Azrolan, N., O'Connell, A., Walsh, A., & Breslow, J. L.
- Affiliations
- Rockefeller University (US)
- Venue
- Science
- Published
- 1990-08-17
- Volume
- 249
- Issue
- 4970
- Pages
- 790-793
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1963872182
- Semantic Scholar
- be3dbcf0ed6239b54ab96520181db05f1ba0399f
- Cited by
- 539
- References
- 32
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 7 · 2023: 9 · 2022: 7 · 2021: 10 · 2020: 9 · 2019: 16 · 2018: 10 · 2017: 17 · 2016: 13 · 2015: 15 · 2014: 16 · 2013: 18 · 2012: 7
- FWCI
- 21.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl033714-17, 5r37hl036461-09)
- National Heart, Lung, and Blood Institute (HL 33714, HL-36461, HL-33435)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- hypertriglyceridemia, apolipoprotein C-III, transgenic mice, gene overexpression, primary hypertriglyceridemia, secondary hypertriglyceridemia, triglyceride metabolism, gene dosage
- MeSH terms
- Animals, Apolipoproteins C, Chylomicrons, Cloning, Molecular, DNA Restriction Enzymes, DNA, Recombinant, Humans, Lipoproteins, VLDL, Mice, Inbred CBA, Mice, Inbred C57BL, Mice, Transgenic, Nucleic Acid Hybridization, RNA, Messenger, Triglycerides, Hypertriglyceridemia, Gene Expression, Mice, Apolipoprotein C-III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.